QQ客服 官方微博 反馈留言

	The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer
	Wan, Xu; Zheng, Xiaoyao; Pang, Xiaoying; Zhang, Zheming; Jing, Tao; Xu, Wei; Zhang, Qizhi
刊名	INTERNATIONAL JOURNAL OF PHARMACEUTICS
	2015
卷号	484期号:1-2
关键词	Lapatinib HSA nanoparticle Triple negative breast cancer 4T1 cells
ISSN号	0378-5173
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4874707
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wan, Xu,Zheng, Xiaoyao,Pang, Xiaoying,et al. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS,2015,484(1-2).
APA	Wan, Xu.,Zheng, Xiaoyao.,Pang, Xiaoying.,Zhang, Zheming.,Jing, Tao.,...&Zhang, Qizhi.(2015).The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.INTERNATIONAL JOURNAL OF PHARMACEUTICS,484(1-2).
MLA	Wan, Xu,et al."The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer".INTERNATIONAL JOURNAL OF PHARMACEUTICS 484.1-2(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。